School of Medicine

Wayne State University School of Medicine
Department of Pathology Bioactive Lipids Research Program
Dr. Kenneth V. Honn - Director

Current Research Projects

Kenneth V. Honn, Principal Investigator
12-Lipoxygenase-Induced Prostate Cancer Radioresistance: A Pivotal Role for NF-kappaB Signaling
P.I.: Kenneth V. Honn - Effort: 5% - Period 7/1/11 – 6/30/14
Funding -  (Direct) $366,400 / (Indirect) $190,528 / Total $556,928
Fund for Cancer Research

Role of GPR31, a high-affinity receptor of 12(S)-HETE, in prostate cancer progress
P.I.: Honn, K.V. - Effort: 5% - Period 6/1/11 – 5/30/12- $75,000
Strategic Research Initiative Grant (SRIG) – Karmanos Cancer Institute

15-LOX1/2 as a novel Putative Tumor Suppressor and Potential Prognostic and Therapeutic Marker in Ovarian Cancer
(CoI: K.V.Honn; PI: R. Ali-Fehmi) 2012-2013 - RFA#KCI-2012-1 - $50,000

Krishnarao Maddipati, Principal Investigator